Moleculin Biotech, Inc.
SEC CIK 1659617 · MBRX · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Klemp Walter V | Director · Chief Executive Officer | filed 2016 - 2026 |
| Cannon Michael D | Director | filed 2016 - 2025 |
| Cermak Elizabeth | Director | filed 2020 - 2025 |
| Climaco John M | Director | filed 2017 - 2025 |
| George Robert E. | Director | filed 2016 - 2025 |
| Yan Joy | Director | filed 2022 - 2025 |
| Northcut Jacqueline | Director | filed 2016 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Picker Donald H | President and COO | filed 2016 - 2026 |
| Foster Jonathan P. | Exec. Vice President and CFO | filed 2016 - 2026 |
| Ploth Louis JR | Chief Financial Officer | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.